EML4 and cancer: First, we confirmed that EML4-ALK localized to punctate structures in the cytoplasm, and not to the PM, by immunofluorescence (IF) in patient-derived cancer cells (H3122) that endogenously express this EML4-ALK variant (Hrustanovic et al., 2015) (Figure 1A).